Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB05126_nanopub.RAdFzHI0BmF26IEcCfOdM_1cg9CcNhlsBpk4BqhHrVRGA#assertion>. }
Showing items 1 to 12 of
12
with 100 items per page.
- drugbank:DB05126 type drugbank_vocabulary:Drug assertion.
- drugbank:DB05126 label "PYM50018 [drugbank:DB05126]" assertion.
- drugbank:DB05126 seeAlso DB05126 assertion.
- drugbank:DB05126 description "PYM50018 is a patented, orally active, neuroprotective and neuroregenerative compound. It is developed for the treatment of amyotrophic lateral sclerosis (ALS, also known as Lou Gehrig's disease). In pre-clinical models, PYM50018 has been observed to protect against neuronal damage, increase neurite outgrowth, reverse oxidative damage and reverse neuronal apoptosis in vitro. When administered orally to a transgenic pre-clinical model of ALS, PYM50018 delays the loss of muscle strength and extends survival time." assertion.
- drugbank:DB05126 identifier "drugbank:DB05126" assertion.
- drugbank:DB05126 title "PYM50018" assertion.
- drugbank:DB05126 drugbank_vocabulary:x-cas cas: assertion.
- drugbank:DB05126 drugbank_vocabulary:drugbank-id "DB05126" assertion.
- drugbank:DB05126 bio2rdf_vocabulary:x-identifiers.org DB05126 assertion.
- drugbank:DB05126 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB05126" assertion.
- drugbank:DB05126 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB05126 bio2rdf_vocabulary:identifier "DB05126" assertion.